Your browser doesn't support javascript.
loading
Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
Yang, Yong-Yu; Shi, Ling-Xing; Li, Jian-He; Yao, Liang-Yuan; Xiang, Da-Xiong.
Afiliação
  • Yang YY; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
  • Shi LX; Department of Pharmacology, Changsha Medical University, Changsha, Hunan 410219, P.R. China.
  • Li JH; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
  • Yao LY; Hunan Provincial Engineering Research Center of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
  • Xiang DX; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
Mol Med Rep ; 19(3): 2245-2253, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30664213

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Nefropatias Diabéticas / Óxido Nítrico Sintase Tipo III / Piperazina Limite: Animals / Humans Idioma: En Revista: Mol Med Rep Ano de publicação: 2019 Tipo de documento: Article País de publicação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Nefropatias Diabéticas / Óxido Nítrico Sintase Tipo III / Piperazina Limite: Animals / Humans Idioma: En Revista: Mol Med Rep Ano de publicação: 2019 Tipo de documento: Article País de publicação: Grécia